1st Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$150,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Notice of benefit and payment parameters for 2014 proposed rule - Cost sharing subsidy reconcilliation methodology Essential health benefits proposed rule - pharmacy benefits Establishment of the multi-state plan program - pharmacy benefit manager transparency requirements Pharmacy compounding

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Notice of benefit and payment parameters for 2014 proposed rule - Cost sharing subsidy reconcilliation methodology Essential health benefits proposed rule - pharmacy benefits Establishment of the multi-state plan program - pharmacy benefit manager transparency requirements Pharmacy compounding

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Office of Personnel Management (OPM)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.